Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database

@article{MariekeSchoonen2009EpidemiologyOI,
  title={Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database},
  author={W. Marieke Schoonen and Gena P Kucera and Jenna E Coalson and Lin Li and Mark D. Rutstein and Fionna S Mowat and Jon P. Fryzek and James A. Kaye},
  journal={British Journal of Haematology},
  year={2009},
  volume={145}
}
The epidemiology of immune thrombocytopenic purpura (ITP) is not well‐characterised in the general population. This study described the incidence and survival of ITP using the UK population‐based General Practice Research Database (GPRD). ITP patients first diagnosed in 1990–2005 were identified in the GPRD. Overall incidence rates (per 100 000 person‐years) and rates by age, sex, and calendar periods were calculated. Survival analysis was conducted using the Kaplan‐Meier and proportional… Expand
Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database
TLDR
There was a relationship between age and sex with ITP incidence, suggesting that patterns of disease burden differ among children and teenagers. Expand
Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea.
TLDR
This population-based study is the first to describe the incidence of immune thrombocytopenia and its treatment reality for patients in Korea. Expand
Prevalence of primary immune thrombocytopenia in Oklahoma
TLDR
These data document for the first time the prevalence of ITP regardless of age, clinical characteristics, insurance status, and source of health care in Oklahoma, and the highest prevalence was among men age 80 years and older. Expand
Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.
TLDR
Incidence of immune thrombocytopenia at a nationwide level (France) with recent data is assessed, with peaks among children and in those >60 years of age, suggesting a lower incidence among Afro-American people. Expand
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports
TLDR
The current strongest estimate of the incidence of acute ITP in children is between 1.9 and 6.4 per 105 children/year; for adults the current strongest estimates are 3.3 per 105 adults/year. Expand
EPIDEMIOLOGY OF IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDREN
TLDR
It was showed that age Male gender increased the risk of severe disease while female gender was risk factors for transforming into chronic ITP, which may provide a good overview of the epidemiology of ITP in Iran. Expand
Prevalence of Diagnosed Adult Immune Thrombocytopenia in the United Kingdom
TLDR
This new analysis of general practice in the UK provides robust prevalence estimates of diagnosed ITP among adults in Europe, which is higher in women and increases with age and over time. Expand
Twenty‐year mortality of adult patients with primary immune thrombocytopenia: a Danish population‐based cohort study
TLDR
It is concluded that mortality rates among ITP patients are higher than in the general population, predominantly as a result of increased cardiovascular disease, infection, bleeding and haematological cancer cause‐specific mortalities. Expand
Original Article Epidemiology of Idiopathic Thrombocytopenic Purpura in Children
TLDR
It was showed that age Male gender increased the risk of severe disease while female gender was risk factors for transforming into chronic ITP, and together with others reported from different centers in Iranian may provide a good overview of the epidemiology of ITP in Iran. Expand
Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review
TLDR
The incidence of ITP in Japan is not markedly different from that of European countries studied to date, and the maximum age-specific incidence is in the eighth decade, contrary to previously published studies. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 49 REFERENCES
The incidence of idiopathic thrombocytopenic purpura in adults increases with age.
TLDR
The incidence rate of idiopathic thrombocytopenic purpura in Danish adults diagnosed from April 1, 1973 to December 31, 1995 increased in the study period, and involved asymptomatic patients and old males who were both symptomatic or not symptomatic. Expand
The epidemiology of immune thrombocytopenic purpura
TLDR
Spontaneous remission occurs more frequently in children than in adults, and intracranial bleeding is uncommon, while adult patients with chronic disease may have a better prognosis than previously recognized, although only a small minority recover spontaneously. Expand
Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patients
TLDR
This population‐based study suggests that the traditional view of adult ITP as being a predominantly chronic disease that preferentially affects females needs to be modified. Expand
Childhood idiopathic thrombocytopenic purpura in the Nordic countries: Epidemiology and predictors of chronic disease
TLDR
The insidious form of idiopathic thrombocytopenic purpura was more frequent in older children and girls, showed little seasonal variation, had milder manifestations and ran a chronic course in more than half the cases. Expand
The Incidence of Idiopathic Thrombocytopenic Purpura (ITP) among Adults in the United Kingdom’s General Practice Research Database (GPRD), 1992–2005.
TLDR
In summary, ITP was diagnosed in approximately 4 adults per 100,000 PYO in the General Practice Research Database, slightly higher than in previous estimates, possibly due to a code-based disease definition without validation by clinical and lab data. Expand
Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.
TLDR
Most adults with ITP have a good outcome with infrequent hospital admissions and no excess mortality, and the absence of gross morbidity and mortality in patients with moderate thrombocytopenia supports clinical practice refraining from further treatment. Expand
Idiopathic thrombocytopenic purpura diagnosed during the second decade of life.
TLDR
Patients 10 to 18 years of age with ITP are more likely than younger children to have chronic disease, and many patients withITP recover without drug therapy or need for splenectomy. Expand
Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study
TLDR
The variable approaches to management of childhood ITP demonstrate the need for prospective clinical trials, which should be feasible within such a study group. Expand
Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany.
TLDR
Although almost all patients had only mild bleeding symptoms, most received Ig and/or GC, and the decision to treat depended mainly on the platelet count, recommendations based primarily on platelet counts must be reconsidered. Expand
High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.
TLDR
It is concluded that age more than 60 years and a previous history of bleeding are major risk factors for severe hemorrhages in adults with ITP. Expand
...
1
2
3
4
5
...